Skip to main content

CaroSpir FDA Approval History

FDA Approved: Yes (First approved August 4, 2017)
Brand name: CaroSpir
Generic name: spironolactone
Dosage form: Oral Suspension
Company: CMP Pharma, Inc.
Treatment for: Heart Failure, Edema, High Blood Pressure

CaroSpir (spironolactone) is an oral suspension formulation of the potassium-sparing diuretic spironolactone indicated for the treatment of heart failure, management of edema, and for use as an add-on therapy in the treatment of hypertension.

Development timeline for CaroSpir

Aug  7, 2017Approval CMP Pharma, Inc. Announces FDA Approval of CaroSpir (spironolactone) Oral Suspension

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.